This study aimed to analyze the patterns of cancer risk-reducing strategies used by unaffected BRCA1/2 mutation carriers with a family history of breast or ovarian cancer who were included in the KOHBRA study. The gene discussed is BRCA1; the disease is ovarian cancer.